allogeneic SCT

Related by string. * Allogeneic : allogeneic epidermal . allogeneic HCT . non personalized allogeneic . allogeneic hematopoietic stem cell . allogeneic endothelial cells . allogeneic hematopoietic cell . allogeneic HSCT . allogeneic stem cell / S. Ct . Sct . S. Ct : autologous SCT . stem cell transplantation SCT . SunGard SCT . TSX VENTURE SSS SCT . SCT Luminis . SCT TSX VENTURE . SCT Banner * *

Related by context. Frequent words. (Click for all words.) 71 allogeneic stem cell 65 decitabine 64 azacitidine 64 neoadjuvant chemotherapy 62 trastuzumab 62 bortezomib 62 adjuvant chemotherapy 62 immunosuppression 62 FOLFOX 61 autologous stem cell 61 topotecan 61 chemoradiation 61 etoposide 60 hematopoietic stem cell 60 virologic failure 60 FOLFIRI 60 sunitinib 60 imetelstat 60 mitoxantrone 60 liver metastases 60 tumor recurrence 60 adjuvant therapy 59 engraftment 59 sustained virologic response 59 GvHD 59 dacarbazine 59 peginterferon 59 allogeneic 59 metastatic renal cell carcinoma 59 temsirolimus 59 adefovir 59 adalimumab 59 PCa 59 distant metastases 58 EGFR inhibitors 58 Trastuzumab 58 vandetanib 58 fludarabine 58 PROMACTA 58 Torisel 58 mediated immunity 58 imatinib 58 cytogenetic response 58 HCV infected 58 neoplastic 58 plus prednisone 58 platelet transfusions 58 chemotherapy regimens 58 gemcitabine 58 TORISEL 57 chronic lymphocytic leukemia CLL 57 stem cell transplantation 57 lupus nephritis 57 anthracyclines 57 dasatinib 57 fluorouracil 57 cyclophosphamide 57 nilotinib 57 vinorelbine 57 fondaparinux 57 interferon alfa 57 CD# + [002] 57 nonresponders 57 xenograft models 57 CMV infection 57 cisplatin 57 Taxotere ® 57 EpCAM 57 tocilizumab 57 myelodysplastic syndromes MDS 56 unresectable 56 VIDAZA 56 evaluable 56 GVHD 56 sorafenib 56 colectomy 56 mRNA expression 56 antiplatelet therapy 56 histologic 56 zoledronic acid 56 rituximab 56 G CSF 56 RECIST criteria 56 docetaxel 56 hematopoietic 56 tamoxifen therapy 56 axitinib 56 serum concentrations 56 partial nephrectomy 56 DMARD 56 pemetrexed 56 free survival PFS 56 squamous 56 median PFS 56 azathioprine 56 antiviral therapy 56 thromboembolic events 55 metastatic tumors 55 Bortezomib 55 androgen independent 55 antihypertensive drugs

Back to home page